Cargando…
Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test
Neutralization assays are important for understanding and quantifying neutralizing antibody responses toward severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 lentivirus surrogate neutralization assay (SCLSNA) can be used in biosafety level 2 (BSL-2) laboratories and has b...
Autores principales: | Merluza, John, Ung, Johnny, Makowski, Kai, Robinson, Alyssia, Manguiat, Kathy, Mueller, Nicole, Audet, Jonathan, Chen, Julie Chih-Yu, Strong, James E., Wood, Heidi, Bello, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927366/ https://www.ncbi.nlm.nih.gov/pubmed/36602312 http://dx.doi.org/10.1128/spectrum.03789-22 |
Ejemplares similares
-
To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
por: Patel, Hursch, et al.
Publicado: (2023) -
Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
por: Valcourt, Emelissa J., et al.
Publicado: (2021) -
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays
por: Valcourt, Emelissa J., et al.
Publicado: (2021) -
Correction for Valcourt et al., “Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays”
por: Valcourt, Emelissa J., et al.
Publicado: (2022) -
Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies
por: Qiu, Hongyu, et al.
Publicado: (2021)